Funded Startups in San Diego
Disclosed deal sizes in this San Diego list show a steep skew: the largest disclosed round is Aspen Neuroscience at $115M on 2025-11-19, while the next-hig…
Disclosed deal sizes in this San Diego list show a steep skew: the largest disclosed round is Aspen Neuroscience at $115M on 2025-11-19, while the next-highest disclosed amounts include Crystalys Therapeutics at $205M (2025-10-04) and National Funding at $145M (2025-05-21). The standout “top-end” bracket is dominated by a handful of large checks (e.g., Crystalys Therapeutics $205M on 2025-10-04; CleanSpark $200M on 2025-04-15; Aspen Neuroscience $115M on 2025-11-19), whereas multiple rounds cluster far lower, including several $5M–$35M financings and smaller outliers like Emission Free Generators at $20K (2025-09-10).
The entries also cluster temporally and by sector/stage: rounds span 2025-03-19 (Biolinq) through 2025-11-19 (Aspen Neuroscience, Eclipse Bioinnovations), with many financings landing in the 2025-06 to 2025-09 window. Biotechnology appears in 11+ of the 50 rows, and “Series Unknown” appears in 16 rows while “undisclosed” appears in 9 rows, indicating a material share of non-standard deal labeling alongside frequent mid-to-late stage tags such as Series A/B/C/D and larger late-stage biotech checks (e.g., Inmagene Biopharmaceuticals $75M on 2025-07-25; Actio Biosciences $66M on 2025-06-18).
Most recent rounds
50 shownRelated listings
Frequently asked
What does the size distribution look like—are there clearly dominant disclosed rounds?
Yes. The largest disclosed amount is Crystalys Therapeutics at $205M (2025-10-04), followed by CleanSpark at $200M (2025-04-15) and National Funding at $145M (2025-05-21). Below that, many disclosed rounds sit in the $15M–$35M range (e.g., Belite Bio $15M on 2025-08-06; Firestorm $35M on 2025-07-16), with much smaller outliers such as Emission Free Generators at $20K (2025-09-10).
Are rounds clustered in a particular part of the calendar in this San Diego set?
Many rounds concentrate between June and September 2025. Examples include Clearspeed $60M (2025-06-26), Direct Communication Solutions $250K (2025-06-20), Actio Biosciences $66M (2025-06-18), Coral Vita $8M (2025-06-06), and UNIGRID $3M (2025-06-02), while the earliest row shown is Biolinq at $90M on 2025-03-19 and the latest is Aspen Neuroscience at $115M on 2025-11-19.
How much of the list is labeled with non-specific deal terms (Series Unknown or undisclosed amounts)?
Out of 50 rows, 16 use “Venture - Series Unknown” or “Series Unknown,” and 9 list an “undisclosed” amount (e.g., ANA Global on 2025-10-18; Raken on 2025-09-11; AetherLab on 2025-04-23). That means a substantial fraction of financings can’t be compared purely by disclosed check size (e.g., XENDEE Corporation has an undisclosed amount on 2025-09-08).
Which sectors show the most repetition, and do they align with the larger disclosed rounds?
Biotechnology is the most repeated sector, appearing in 11+ entries across dates (e.g., Aspen Neuroscience $115M on 2025-11-19; Inmagene Biopharmaceuticals $75M on 2025-07-25; Trefoil Therapeutics $5M on 2025-05-06). Several of the largest disclosed checks are also biotech-linked (e.g., Crystalys Therapeutics $205M on 2025-10-04; Cleanspark is labeled Energy but the top-end bracket still includes multiple biotech financings).
Are there notable outliers by stage or size that sales or diligence teams should flag first?
Two size outliers stand out at the extremes: Emission Free Generators at $20K (2025-09-10) and multiple sub-$1M/low-$K rounds like Ride Krew at $20K (2025-06-03) versus top-end disclosed rounds like Crystalys Therapeutics at $205M (2025-10-04). Stage-wise, the highest disclosed amounts are tied to later labels such as Series A/C and biotech-specific financings (e.g., Aspen Neuroscience Series C $115M on 2025-11-19; SelectION Series C $5M on 2025-09-16), while many entries remain “Series Unknown” (e.g., Eclipse Bioinnovations $5M on 2025-11-19).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.